Max Verstappen isn't promising he’ll stick out his current Formula 1 contract. The reigning four-time world champion made it clear—the next-generation 2026 cars better be fun to drive, or he'll walk.

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all the ...